A Rollover Study to Provide Continued Treatment With Eltrombopag

NCT01957176 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombocytopaenia

Interventions

DRUG: Eltrombopag (ELT)

Sponsor

Novartis Pharmaceuticals